MAPT expression and splicing is differentially regulated by brain region: Relation to genotype and implication for tauopathies

Human Molecular Genetics

Volumn 21, Issue 18, 2012, Pages 4094-4103

  Trabzuni, Daniah ^a,b   Wray, Selina ^a   Vandrovcova, Jana ^a   Ramasamy, Adaikalavan ^a,c   Walker, Robert ^d   Smith, Colin ^d   Luk, Connie ^a   Gibbs, J Raphael ^a,e   Dillman, Allissa ^e   Hernandez, Dena G ^a,e   Arepalli, Sampath ^e   Singleton, Andrew B ^e   Cookson, Mark R ^e   Pittman, Alan M ^a   De silva, Rohan ^a   Weale, Michael E ^c   Hardy, John ^a   Ryten, Mina ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ARTICLE; BRAIN REGION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENE CONTROL; GENE EXPRESSION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RNA SPLICING; TAU GENE; TAUOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; CASE-CONTROL STUDIES; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; QUANTITATIVE TRAIT LOCI; RNA SPLICE SITES; TAU PROTEINS; TAUOPATHIES; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84865791125     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds238     Document Type: Article

References (48)

1. Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E. and Hutton, M. (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet., 8, 711-715.
2. Hoglinger, G.U., Melhem, N.M., Dickson, D.W., Sleiman, P.M., Wang, L.S., Klei, L., Rademakers, R., de Silva, R., Litvan, I., Riley, D.E. et al. (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat. Genet., 43, 699-705.
3. Houlden, H., Baker, M., Morris, H.R., MacDonald, N., Pickering-Brown, S., Adamson, J., Lees, A.J., Rossor, M.N., Quinn, N.P., Kertesz, A. et al. (2001) Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology, 56, 1702-1706.
4. Golbe, L.I., Lazzarini, A.M., Spychala, J.R., Johnson, W.G., Stenroos, E.S., Mark, M.H. and Sage, J.I. (2001) The tau A0 allele in Parkinson's disease. Mov. Disord., 16, 442-447.
5. Lill, C.M., Roehr, J.T., McQueen, M.B., Kavvoura, F.K., Bagade, S., Schjeide, B.M., Schjeide, L.M., Meissner, E., Zauft, U., Allen, N.C. et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene Database. PLoS Genet., 8, e1002548.
6. Nalls, M.A., Plagnol, V., Hernandez, D.G., Sharma, M., Sheerin, U.M., Saad, M., Simon-Sanchez, J., Schulte, C., Lesage, S., Sveinbjornsdottir, S. et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet, 377, 641-649.
7. Gerrish, A., Russo, G., Richards, A., Moskvina, V., Ivanov, D., Harold, D., Sims, R., Abraham, R., Hollingworth, P., Chapman, J. et al. (2012) The role of variation at AbetaPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J. Alzheimers Dis., 28, 377-387.
8. Myers, A.J., Kaleem, M., Marlowe, L., Pittman, A.M., Lees, A.J., Fung, H.C., Duckworth, J., Leung, D., Gibson, A., Morris, C.M. et al. (2005) The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum. Mol. Genet., 14, 2399-2404.
9. Stefansson, H., Helgason, A., Thorleifsson, G., Steinthorsdottir, V., Masson, G., Barnard, J., Baker, A., Jonasdottir, A., Ingason, A., Gudnadottir, V.G. et al. (2005) A common inversion under selection in Europeans. Nat. Genet., 37, 129-137.
10. Goedert, M., Spillantini, M.G., Jakes, R., Rutherford, D. and Crowther, R.A. (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron, 3, 519-526.
11. Goedert, M., Spillantini, M.G., Potier, M.C., Ulrich, J. and Crowther, R.A. (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J., 8, 393-399.
12. Zody, M.C., Jiang, Z., Fung, H.C., Antonacci, F., Hillier, L.W., Cardone, M.F., Graves, T.A., Kidd, J.M., Cheng, Z., Abouelleil, A. et al. (2008) Evolutionary toggling of the MAPT 17q21.31 inversion region. Nat. Genet., 40, 1076-1083.
13. Pittman, A.M., Myers, A.J., Duckworth, J., Bryden, L., Hanson, M., Abou-Sleiman, P., Wood, N.W., Hardy, J., Lees, A. and de Silva, R. (2004) The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet., 13, 1267-1274.
14. Fung, H.C., Evans, J., Evans, W., Duckworth, J., Pittman, A., de Silva, R., Myers, A. and Hardy, J. (2005) The architecture of the tau haplotype block in different ethnicities. Neurosci. Lett., 377, 81-84.
15. Pittman, A.M., Myers, A.J., Abou-Sleiman, P., Fung, H.C., Kaleem, M., Marlowe, L., Duckworth, J., Leung, D., Williams, D., Kilford, L. et al. (2005) Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet., 42, 837-846.
16. Feany, M.B., Mattiace, L.A. and Dickson, D.W. (1996) Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J. Neuropathol. Exp. Neurol., 55, 53-67.
17. Luk, C., Giovannoni, G., Williams, D.R., Lees, A.J. and de Silva, R. (2009) Development of a sensitive ELISA for quantification of threeand four-repeat tau isoforms in tauopathies. J. Neurosci. Methods, 180, 34-42.
18. Goedert, M. (2004) Tau protein and neurodegeneration. Semin. Cell Dev. Biol., 15, 45-49.
19. Sergeant, N., Wattez, A. and Delacourte, A. (1999) Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively 'exon 10' isoforms. J. Neurochem., 72, 1243-1249.
20. Trabzuni, D., Ryten, M., Walker, R., Smith, C., Imran, S., Ramasamy, A., Weale, M.E. and Hardy, J. (2011) Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies. J. Neurochem., 119, 275-282.
21. Gibbs, J.R., van der Brug, M.P., Hernandez, D.G., Traynor, B.J., Nalls, M.A., Lai, S.L., Arepalli, S., Dillman, A., Rafferty, I.P., Troncoso, J. et al. (2010) Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet., 6, e1000952.
22. Boutajangout, A., Boom, A., Leroy, K. and Brion, J.P. (2004) Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. FEBS Lett., 576, 183-189.
23. Luk, C., Vandrovcova, J., Malzer, E., Lees, A. and de Silva, R. (2010) Brain tau isoform mRNA and protein correlation in PSP brain. Trans. Neurosci., 1, 30-36.
24. Myers, A.J., Gibbs, J.R., Webster, J.A., Rohrer, K., Zhao, A., Marlowe, L., Kaleem, M., Leung, D., Bryden, L., Nath, P. et al. (2007) A survey of genetic human cortical gene expression. Nat. Genet., 39, 1494-1499.
25. Myers, A.J., Pittman, A.M., Zhao, A.S., Rohrer, K., Kaleem, M., Marlowe, L., Lees, A., Leung, D., McKeith, I.G., Perry, R.H. et al. (2007) The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis., 25, 561-570.
26. Naiser, T., Ehler, O., Kayser, J., Mai, T., Michel, W. and Ott, A. (2008) Impact of point-mutations on the hybridization affinity of surface-bound DNA/DNA and RNA/DNA oligonucleotide-duplexes: comparison of single base mismatches and base bulges. BMC Biotechnol., 8, 48.
27. Caffrey, T.M., Joachim, C. and Wade-Martins, R. (2008) Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. Neurobiol. Aging, 29, 1923-1929.
28. Gibb, G.M., de Silva, R., Revesz, T., Lees, A.J., Anderton, B.H. and Hanger, D.P. (2004) Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. Brain Res. Mol. Brain Res., 121, 95-101.
29. Chen, J., Kanai, Y., Cowan, N.J. and Hirokawa, N. (1992) Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons. Nature, 360, 674-677.
30. Frappier, T.F., Georgieff, I.S., Brown, K. and Shelanski, M.L. (1994) tau Regulation of microtubule-microtubule spacing and bundling. J. Neurochem., 63, 2288-2294.
31. Lee, G. (2005) Tau and src family tyrosine kinases. Biochim. Biophys. Acta, 1739, 323-330.
32. Lee, G., Newman, S.T., Gard, D.L., Band, H. and Panchamoorthy, G. (1998) Tau interacts with src-family non-receptor tyrosine kinases. J. Cell Sci., 111, 3167-3177.
33. Zhong, Q., Congdon, E.E., Nagaraja, H.N. and Kuret, J. (2012) Tau isoform composition influences the rate and extent of filament formation. J Biol Chem., 287, 20711-20719.
34. Ittner, L.M., Ke, Y.D., Delerue, F., Bi, M., Gladbach, A., van, E.J., Wolfing, H., Chieng, B.C., Christie, M.J., Napier, I.A. et al. (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell, 142, 387-397.
35. Benovoy, D., Kwan, T. and Majewski, J. (2008) Effect of polymorphisms within probe-target sequences on olignonucleotide microarray experiments. Nucleic Acids Res., 36, 4417-4423.
36. Alberts, R., Terpstra, P., Li, Y., Breitling, R., Nap, J.-P. and Jansen, R.C. (2007) Sequence polymorphisms cause many false cis eQTLs. PLoS ONE, 2, e622.
37. Millar, T., Walker, R., Arango, J.C., Ironside, J.W., Harrison, D.J., MacIntyre, D.J., Blackwood, D., Smith, C. and Bell, J.E. (2007) Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J. Pathol., 213, 369-375.
38. Beach, T.G., Sue, L.I., Walker, D.G., Roher, A.E., Lue, L., Vedders, L., Connor, D.J., Sabbagh, M.N. and Rogers, J. (2008) The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank, 9, 229-245.
39. Hernandez, D.G., Nalls, M.A., Moore, M., Chong, S., Dillman, A., Trabzuni, D., Gibbs, J.R., Ryten, M., Arepalli, S., Weale, M.E. et al. (2012) Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain. Neurobiol. Dis., 47, 20-28.
40. Barbosa-Morais, N.L., Dunning, M.J., Samarajiwa, S.A., Darot, J.F., Ritchie, M.E., Lynch, A.G. and Tavare, S. (2010) A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data. Nucleic Acids Res., 38, e17.
41. Li, Y., Willer, C., Sanna, S. and Abecasis, G. (2009) Genotype imputation. Annu. Rev. Genomics Hum. Genet., 10, 387-406.
42. Li, Y., Willer, C.J., Ding, J., Scheet, P. and Abecasis, G.R. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.
43. RDC-Team. (2011) RDC Team (R Development Core Team). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria.
44. Hanger, D.P., Gibb, G.M., de Silva, R., Boutajangout, A., Brion, J.P., Revesz, T., Lees, A.J. and Anderton, B.H. (2002) The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies. FEBS Lett., 531, 538-542.
45. de Silva, R., Lashley, T., Gibb, G., Hanger, D., Hope, A., Reid, A., Bandopadhyay, R., Utton, M., Strand, C., Jowett, T. et al. (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol. Appl. Neurobiol., 29, 288-302.
46. Dickson, D.W., Hauw, J.-J., Agid, Y. and Litvan, I. (2011) In Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Wiley-Blackwell, pp. 135-155.
47. Braak, H. and Braak, E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol., 82, 239-259.
48. Compta, Y., Parkkinen, L., O'Sullivan, S.S., Vandrovcova, J., Holton, J.L., Collins, C., Lashley, T., Kallis, C., Williams, D.R., de Silva, R. et al. (2011) Lewy-and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? Brain, 134, 1493-1505.